Red Spruce Capital’s Zimmer Biomet ZBH Stock Holding History

Red Spruce Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,881	Closed	-$606K	–	90
2021 Q2	$606K	Buy	3,881 +58	+2%	+$9.39K	0.36%	73
2021 Q1	$594K	Buy	3,823 +172	+5%	+$26.6K	0.38%	69
2020 Q4	$546K	Buy	3,651 +193	+6%	+$27.3K	0.38%	72
2020 Q3	$457K	Buy	3,458 +110	+3%	+$14.4K	0.37%	72
2020 Q2	$388K	Hold	3,348	–	–	0.33%	71
2020 Q1	$329K	Buy	3,348 +18	+0.5%	+$2.36K	0.34%	75
2019 Q4	$484K	Buy	+3,330	New	+$460K	0.4%	67

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Red Spruce Capital's ZBH Position: Q3 2021 in Review

Red Spruce Capital sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 3,881 shares — an estimated $606K sold.

Red Spruce Capital first reported a position in ZBH in Q4 2019 and held it in 7 quarters. The position peaked at $606K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Red Spruce Capital reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Red Spruce Capital sold 3,881 Zimmer Biomet shares in Q3 2021, an estimated $606K.
Red Spruce Capital first reported a position in Zimmer Biomet in Q4 2019 and held it in 7 quarters.
Red Spruce Capital's Zimmer Biomet position peaked at $606K in Q2 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Red Spruce Capital's 13F filing for Q3 2021, filed 4 Oct 2021.